Premium RX national LLC:1334071 [22-013338]- fludarabine
Ended Purchase Order Awarded
- Contract number
- 75N90022P00473
- Awardee
-
Premium RX National LLC UEI GQENU1KZLN59
- Awarding agency
-
NIH Clinical Center
National Institutes of Health, Department of Health and Human Services
- Obligated
- $0
Award facts
- Contract value
- $0.00 Current and potential, with all options
- Completion date
- Current and potential, with all options
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Competed under SAP · 1 offer Simplified Acquisition
- Pricing
- Firm Fixed Price
- Place of performance
- Bethesda, MD 20814, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Terminate for Convenience | -$24,375 | |
| Original award | $24,375 |
Quick answers
Who was awarded contract 75N90022P00473?
75N90022P00473 was awarded to Premium RX National LLC by NIH Clinical Center (National Institutes of Health) on August 12, 2022.
How much is contract 75N90022P00473 worth?
The government has obligated $0 on 75N90022P00473.
Was contract 75N90022P00473 competed?
The extent of competition for 75N90022P00473 was competed under sap. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award